It’s all about the FDA approval, once (or if) we have it, demand will sky rocket as physicians will be very well inclined to prescribe it to their patients. The phase 2 data is very strong and this product is low risk, so I envisage we should obtain approval from the FDA.
This is a long play, I wouldn’t expect a major increase in sales over the next 6 months.
It’s all about the FDA approval, once (or if) we have it, demand...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $20.86M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 34.0¢ | $9.58K | 27.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11600 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 6296 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| TRP (ASX) Chart |